← FDA Drug Approvals (Drugs@FDA)

TICAGRELOR

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS INC · Approved 2018-09-04

Drug application

FDA Application #

ANDA208390

Application type

Abbreviated New Drug Application (Generic)

Brand name

TICAGRELOR

Generic name

TICAGRELOR

Active ingredients

TICAGRELOR

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

WATSON LABS INC

Manufacturer

Teva Pharmaceuticals, Inc.

First approval

2018-09-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown